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Edited by Gianni CesareniAbstract Acetylcholinesterase (AChE) is likely to have roles
other than the hydrolysis of acetylcholine, e.g., related to
developmental processes like neurite outgrowth, diﬀerentiation
and adhesion. Here, we investigated whether AChE can function
as a heterophilic cell adhesion molecule and searched for proteins
interacting with it. Using the yeast two-hybrid method and a
mouse brain cDNA library, we have identiﬁed an interaction
between a partial cDNA encoding the globular domain IV of
laminin chain b1 and the amino acids 240–503 of mouse AChE.
Biochemical co-immunoprecipitation assays conﬁrmed the
genetic results. We suggest that AChE, by interacting with
laminin-1, is able to exert changes in adhesion signaling
pathways.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Acetylcholinesterase (AChE) is known as the enzyme that
terminates the action of the neurotransmitter acetylcholine
(ACh) at neuromuscular junctions and brain cholinergic syn-
apses. Apart from its catalytic function, strong evidence over
the past decade established novel non-catalytic functions of
AChE, in particular by aﬀecting neurite outgrowth and cell
adhesion [1–6]. AChE is expressed very early in neural devel-
opment before the onset of cholinergic neurotransmission [7–
9], thereby aﬀecting processes of migration, diﬀerentiation and
synaptogenesis by a mechanism that is unrelated to its classic
ACh hydrolyzing activity. Part of the non-catalytic AChE
activities is assigned to sequence homologies between AChE
and a family of cell adhesion molecules, including the Dro-
sophila neurotactin and mammalian neuroligins [10,11].
Although these proteins have a structural organization similar
to the enzyme acetylcholinesterase, their cholinesterase-like
domain lacks enzymatic activity and functions through a
protein–protein interaction motif [12]. Due to these homolo-
gies, and also to pharmacological and other molecular studies,* Corresponding author. Fax: +49-6151-166548.
E-mail address: layer@bio.tu-darmstadt.de (P.G. Layer).
Abbreviations: AChE, acetylcholinesterase; ACh, acetylcholine; aa,
amino acid; CNS, central nervous system; DO, drop-out
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.08.078it was established that AChE can function as a cell adhesion
molecule [1,13,14]. It is generally assumed that an unknown
heterologous binding partner for AChE must be involved in its
adhesive functions. This partner should be able to transduce
signals into cells and be expressed already at early develop-
mental stages.
Laminin-1 is a part of the basement membrane and thus is
ideally placed as a potential ligand for AChE in the developing
nervous system. Laminin has many and varied functions that
are mediated by binding to various components of the base-
ment membrane [15–17]. As a cell attachment factor, it pro-
motes neurite outgrowth and inﬂuences neuron migration,
growth, morphology, and adhesion, functions important in
tissue repair. A number of laminin-binding cellular proteins
have been characterized, including a variety of cell surface
integrins that mediate the interactions of cells with laminin
[18,19]. Recent studies showed that human AChE also binds to
mouse laminin-1 and collagen IV in vitro by an electrostatic
mechanism [20].
To gain insight into the cell adhesion promoting functions of
acetylcholinesterase, we here searched for proteins interacting
with it, using a yeast two-hybrid screen. We identiﬁed several
AChE-binding partners, some seemingly well suited to trans-
duce signals into cells. Here, we report that laminin-1b was
identiﬁed as a binding partner of mouse AChE using a yeast
two-hybrid screening. Co-immunoprecipitation assays con-
ﬁrmed the results of the yeast screen. The interaction between
AChE and laminin-1 could well be one of the missing links
between AChE and other neuronal cell adhesion molecules like
integrins. Possible roles of the AChE laminin-1 interaction in
neurite outgrowth and synaptogenesis are discussed.2. Materials and methods
2.1. Plasmid construction
pVJL11-N583AChE was constructed by inserting the core domain
of mouse AChE, encoding the amino acids (aa) 1–583, into pVJL11
vector, a pBTM116 derivative with modiﬁed polylinker (kindly pro-
vided by Dr. J. Camonis). The bait AChE was ampliﬁed by PCR with
Pfu polymerase (Stratagene) and cloned in frame at EcoRI and BamHI
restriction sites of the pVJL11 vector. Two plasmids encoding C-ter-
minally truncated baits were also constructed: pVJL11-N472AChE (aa
1–472) and pVJL11-N263AChE (aa 155–418). pVJL11-laminC and
pVJL11-p53 were constructed by the excision of cDNA encoding for
the aa 67–230 of human laminC from pLaminC vector (Stratagene)
and of cDNA encoding for the aa 72–390 of murine p53 and in-frame
ligation in pVJL11. The sequences of all constructs were conﬁrmed byation of European Biochemical Societies.
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for interaction were a gift of Dr. J. Camonis and are described else-
where [21]. The core domain of AChE (aa 1–583) was expressed using
pCDNA3 in HEK293 cells (pCDNA3-AChE kindly provided by Prof.
Dr. P. Taylor).
2.2. Yeast two-hybrid screening
The two-hybrid system used in this study has already been described
[22,23]. Amino acids 1–583 of the mouse AChE fused to the LexA
binding domain were used as bait to screen an adult mouse brain
cDNA library fused to Gal4 activation domain in pACT2 vector
(Clontech). The yeast strain L40, pre-transformed with the pVJL11-
N583AChE recombinant vector, was then transformed with 60 lg
cDNA of a mouse brain library. Approximately 2 · 106 yeast trans-
formants were screened. Positive clones were selected for 6 days on
drop-out (DO) agar plates (-Leu, -Trp, -His) and assayed for b-
galactosidase activity. To assess the speciﬁcity of the interaction, po-
sitive library recombinant vectors were used to co-transform L40 with
pVJL11-N583AChE, pVJL11 empty vector, pVJL11-Lamin or
pVJL11-p53. The cDNA inserts from the AChE interacting clones
were sequenced using the dideoxy termination method. When two-
hybrid results are presented, the results of b-galactosidase test on ﬁlter
paper are shown. There was no discrepancy between His auxotrophy
test and the b-galactosidase test.
2.3. Antibodies
Antibodies used were: polyclonal goat anti-AChE mouse E-19
(Santa Cruz Biotechology, Germany, Product No. sc-6432), raised
against the N-terminus of AChE, polyclonal rabbit anti-laminin-1
mammalian species (Sigma, Germany, Product No. L 9393), mono-
clonal rat anti-laminin 1b mouse (Chemicon International, Germany,
Product No. MAB 1928), goat anti-rabbit horseradish peroxidase
conjugated (Sigma, Product No. A 0545), goat anti-rat horseradish
peroxidase conjugated (Sigma, Product No. A 9037), and rabbit anti-
goat horseradish peroxidase conjugated (Sigma, Product No. A 8919).
2.4. Cell culture, transient transfections
HEK293 cells were cultured in high glucose Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine serum, 2 mM
glutamine, 20 units/ml penicillin and 20 lg/ml streptomycin. The cells
were grown on 9 cm dishes until 50–60% conﬂuency. They were
transfected for 8 h with pCDNA3-AChE, using the DOTAP liposomal
transfection reagent (Roche, Germany) and following the manufac-
turer’s instructions. After 48 h, cells were rinsed, collected by centri-
fugation, and resuspended in phosphate buﬀered saline, pH 7.4, with
0.1% Triton X-100 plus complete protease inhibitors cocktail (Sigma).
Clear supernatants were prepared by centrifugation at 12 000· g, 4 C,
for 10 min. Mouse brain extracts were prepared as follows: mice were
euthanized by cervical dislocation and the brain was collected and
stored frozen at )80 C or directly homogenized in 10 ml of 10 mM
Tris–HCl, pH 7.4, 1 mM EDTA, and 0.02% NaN3 plus fresh protease
inhibitors (Sigma) with a sonicator by 4 times 20 s pulses. After ul-
tracentrifugation at 150 000· g at 4 C, for 60 min, the pellet was re-
suspended in 10 vol of 20 mM Na-phosphate, pH 7.0, 1 mM EDTA, 1
M NaCl, 0.5% Triton X-100, and 0.02% NaN3 plus protease inhibi-
tors, with a sonicator 4 times 20 s pulses. The extract was centrifuged
at 150 000· g, 4 C for 60 min. The supernatant, the ﬁnal mouse brain
membrane extract, was saved, aliquoted and stored at )80 C. Protein
content and acetylcholinesterase activity [24] was determined in dif-
ferent fractions. The brain extract buﬀer was then changed by dialysis
with phosphate buﬀered saline plus 0.1% Triton X-100, to minimialize
the high salt content interference with the binding studies.
2.5. Co-immunoprecipitations and Western blot analysis
HEK-293 cell lysate (1 ml, 2 mg protein/ml) plus 5 lg laminin-1
(Sigma) was incubated with anti-AChE (10 ll, 200 lg/ml stock con-
centration) or anti-laminin antibodies (5 lg monoclonal, 15 ll poly-
clonal) at 4 C rotation for 16 hours, followed by incubation with 100
ll Protein G–agarose (Amersham Pharmacia Biotechnology) for 2 h at
4 C. Likewise, the brain membranes fraction (1 ml) was subjected to
immunoprecipitation by anti-AChE or anti-laminin antibodies. Con-
trol immunoprecipitates were carried out using goat pre-immune se-
rum, 1:100. The resin was collected by centrifugation, washed three
times by 1 ml phosphate buﬀered saline, pH 7.4, 250 mM NaCl, plus
0.1% Triton X-100, resuspended in 30 ll SDS gel-loading buﬀer(50 mM Tris, pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol,
and 5% b-mercaptoethanol), and boiled for 5 min. After centrifuga-
tion, the supernatant was subjected to SDS–PAGE in a 7.5% acryl-
amide gel. The gel was stained with Coomassie brilliant blue R250. For
Western blot analysis, the proteins were electrotransferred from the
acrylamide gel to a nitrocellulose membrane (Schleicher & Schuell,
Germany). The membrane was blocked in 3% non-fat dried milk in
Tris-buﬀered saline containing 0.05% Tween 20 for 2 h at room tem-
perature, to avoid unspeciﬁc binding of the antibody. Polyclonal an-
tibodies against mouse AChE and mouse laminin-1 were diluted at
1:1000 and 1:500, respectively, and incubated with the membrane for 2
h. For detection, horseradish peroxidase-conjugated goat anti-rabbit
and anti-rat or rabbit anti-goat antibodies (1:10 000, 1 h) and the ECL
chemiluminescence system (Amersham Pharmacia Biotech) were used.3. Results
3.1. Two-hybrid screen
In order to identify proteins that associate with AChE, we
performed a yeast two-hybrid screening of a cDNA library
from adult mouse brain, using as bait the core region of AChE,
which is common to all AChE molecular forms. Approxi-
mately 2· 106 yeast transformants were screened and plasmid
DNAs of the stronger interactions, that were able to grow in
selective media (-Trp, -Leu, -His) and displayed a strong b-
galactosidase signal, were isolated. 96 colonies were Trpþ,
Leuþ, Hisþ and LacZþ. Plasmid DNA of the yeast two-hybrid
screen positive clones was transformed in E. coli, library
plasmids were isolated, redundant clones were eliminated by
analysis of insert sizes and sequencing. 23 clones that inter-
acted with the AChE fusion protein and not with negative
control fusion proteins (e.g., lamin, p53) were identiﬁed. One
of the 23 remaining clones had 98% homology at the nucleo-
tide sequence level with mouse laminin-1b and interacted
speciﬁcally with AChE. The clone contains an 898 bp laminin-
1b fragment, located closer to the N-terminal region of the
chain, and it includes the globular domain IV and part of the
cysteine-rich domain III. Fig. 1 shows the signals displayed by
AChE and laminin transformants in a b-galactosidase test. To
determine the region of AChE involved in interaction, shorter
AChE constructs with N- and C-termini deletions were tested.
The pVJL11-N263AChE construct was the shortest that could
activate the LacZ reporter gene (Fig. 1). The data indicated
that in the view of the results of the b-galactosidase ﬁlter lift
assay, the interaction between these two proteins is moderately
strong and that the region containing 240th aa residue to 503th
aa residues of AChE is essential for interaction with laminin-
1b.3.2. Co-immunoprecipitation
To verify the yeast two-hybrid interaction of AChE with
laminin-1 by an independent technique, we chose the co-im-
munoprecipitation approach. AChE is a glycosylated extra-
cellular protein that contains three di-sulﬁde bridges, so that a
technique that involves expression in bacteria, like in vitro
pull-downs, is not suitable. The HEK-293 cells, being mam-
malian, allow the correct post-translational modiﬁcation and
expression of AChE.
For co-immunoprecipitation studies, we used mouse brain
membrane extracts, or, alternatively, AChE was expressed by
transient transfection of pCDNA3-AChE plasmid in HEK-293
cells. The brain extracts expressed high levels of AChE, as
Fig. 1. Yeast two-hybrid interactions of laminin-1b with diﬀerent
AChE constructs. L40 yeast cells were transformed with pair wise
combinations of plasmids expressing proteins fused to the LexA
binding domain from pVJL11 plasmid and laminin-1b fused to the
Gal4 activation domain from the pACT2 plasmid. A b-galactosidase
activity assay on yeast colonies was performed. The pVJL11-N583A
and pVJL11-N472A constructs activated strongly the LacZ reporter
gene when transformed with pACT2-laminin. pVJL11-N263A and
pACT2-laminin activated weakly the LacZ reporter gene. pACT2-
laminin did not activate LacZ when transformed with pVJL11,
pVJL11-p53, or pVJL11-laminC.
Fig. 2. Co-immunoprecipitation of AChE and laminin-1. (A) AChE
co-immunoprecipitates with laminin-1. Proteins were immunoprecipi-
tated with rabbit anti-laminin-1 (lane 1) or goat pre-immune serum
(lane 3) from brain membrane extracts containing 1 mg of total pro-
tein. After immunoprecipitation they were subjected to immunoblot
analysis with an anti-AChE polyclonal antibody. Lane 2 represents a
brain extract subjected to immunodetection with a polyclonal anti-
AChE antibody. (B) Laminin-1 co-immunoprecipitates with AChE.
Proteins were precipitated with pre-immune serum (lane 2) or excess
AChE polyclonal antibody (lane 3) from lysates of HEK293 cells
containing 1mg of total cellular protein, resolved by SDS-PAGE,
transferred to nitrocellulose membranes, and immunoblotted with
anti-laminin-1 antibody. Lane 1 represents a HEK293 cell lysate
containing 20 lg of total cellular protein loaded directly on the gel to
test the presence of laminin-1.
Table 1
AChE and laminin-1 form a salt-dependent immunocomplex
Co-immunoprecipitation
buﬀer/salt concentration
Binding of AChE to
laminin-1
0.2% Triton X-100, 500 mM NaCl )
0.2% Triton X-100, 200 mM NaCl )
0.1% Triton X-100, 100 mM NaCl )/+
0.1% Triton X-100, 25 mM NaCl +
0.1% Triton X-100, w/o salt +
All buﬀers included 50 mM Tris–HCl, pH 8.0, 1 mM EDTA and 1%
protease inhibitors. ) represents no binding, ‘+’ binding, ‘+/)’ weak
interaction.
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1 content (Western blot, not shown). Therefore, laminin-1
(Sigma) was added to cell lysates or brain extracts before im-
munoprecipitation. We then determined whether AChE asso-
ciates with laminin-1. To this end, proteins from lysates of
HEK-293 cells or from brain membrane extract were precipi-
tated with goat pre-immune serum or with a mixture of a
polyclonal and a monoclonal antibody to laminin-1. Then,
they were resolved by SDS–PAGE, transferred to nitrocellu-
lose membranes, and immunoblotted with a polyclonal anti-
body speciﬁc for mouse AChE (Fig. 2A). AChE was detected
in brain homogenate (Fig. 2A, lane 1) and in laminin-1 im-
munoprecipitates (Fig. 2A, lane 2), but not in control immu-
noprecipitates (Fig. 2A, lane 3). To determine whether
laminin-1 co-immunoprecipitates with AChE, proteins from
lysates of HEK-293 cells overexpressing AChE were immu-
noprecipitated with a goat polyclonal anti-mouse AChE and
subjected to immunoblot analysis with a polyclonal antibody
speciﬁc for mouse laminin-1 (Fig. 2B). Laminin-1 (a1 chain
400 kDa corresponding to the upper band, chain b1 and c1 205
kDa corresponding to the lower band) was detected in cell
lysates (Fig. 2B, lane 1), in AChE immunoprecipitates
(Fig. 2B, lane 3) but not in control immunoprecipitates
(Fig. 2B, lane 2). To optimize the formation of immune
complexes, diﬀerent buﬀers were used for the step of coupling
the antigen to the antibody (see Table 1). High salt concen-tration of the buﬀer inhibited the binding. Together, these
ﬁndings indicated that AChE associates with laminin-1.4. Discussion
Using a yeast two-hybrid screen, we were able to identify
here a fragment of laminin-1b chain as interaction partner of
AChE. An obvious concern when using extracellular proteins
in a yeast two-hybrid is that these proteins are often glycosy-
lated and contain disulﬁde bridges. However, AChE was pre-
viously successfully expressed in yeast (Pichia pastoris), the
puriﬁed protein having properties comparable with the native
AChE, a molecular weight of 67 kDa, suggesting a glycosyl-
ation, and exhibited the same inhibition properties [25]. Our
co-immunoprecipitation studies conﬁrmed the yeast two-
hybrid screen results. Moreover, these studies indicate that the
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NaCl used in the interaction buﬀer (not shown). High ionic
buﬀers (250–500 mM NaCl) yielded in no binding between
these two proteins. These results substantiate earlier indica-
tions that an electrostatic mechanism may be involved in
binding [20]. Electrostatic complementarity between interact-
ing proteins has been found to be one of the major driving
forces for protein complex formation [26]. Examination of the
three-dimensional structure of AChE showed the enzyme to be
characterized by a marked asymmetric spatial distribution of
charged residues. It was proposed that the surface potentials
are related to other functions than catalysis, like adhesion [27].
Moreover, AChE is a member of a class of adhesion proteins
that, because of their common electrostatic and structural
motif, were called electrotactins [27]. Therefore, the high in-
teraction dependence on the salt concentration supports an
electrostatic mechanism of this interaction.
The region of AChE essential for the interaction with lam-
inin-1 lacks the catalytic serine 200. That the catalytic triad is
not involved in the binding is not unexpected. It was already
demonstrated, using speciﬁc catalytic site inhibitors, that the
developmental functions of AChE, e.g., neurite outgrowth and
diﬀerentiation, are independent of its enzymatic activity [1–3].
The interaction site on laminin-1 is located on the N-terminal
region of the b-chain and includes the globular domain IV and
a part of the cysteine-rich domain III. The globular domains
are important in laminin self-assembly and also for the binding
to extracellular matrix components [28]. To date, the globular
domain IV has no speciﬁc function. It is therefore a most
signiﬁcant ﬁnding that this domain may interact with AChE.
Here, we propose a model for a novel developmental func-
tion of AChE, based on its interaction with laminin-1. The
most likely mechanism through which AChE sends signals into
the cell is the following: during development, the early secreted
AChE binds to the laminin chain b1. Laminin-1b is expressed
very early and ubiquitously during development. The laminin-
1 mRNA is expressed at the two or four cells stage [29], the
protein becomes detectable at the morula stage of the mouse
[30]. Laminin-1 binds to integrin receptors, a class of cell ad-
hesion molecules known to be involved in neuronal migration
during CNS development, most likely by mediating the ad-
hesive interactions between neurons and radial glial ﬁbers. It is
well established that cell adhesion molecules such as integrins
play an important role in building and maintaining synaptic
structure during CNS development [31]. By binding to inte-
grins, laminin-1 could thus send signals intra-neuronally.
Possibly, AChE will be also able to signal using this mecha-
nism. The intracellular eﬀect of AChE could lead to changes in
signaling pathways and to remodeling of actin cytoskeletal
structures.
Further studies, including the co-immunoprecipitation of an
AChE–laminin–integrin complex, or disruption of the inter-
action between the two proteins, will help to validate this
model. At any rate, the search for proteins interacting with
AChE represents an important tool for further deﬁning its
developmental functions.
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